{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:17:24Z","timestamp":1771424244877,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402375"],"award-info":[{"award-number":["82402375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Provincial Health Youth Research Project","award":["2023QNA050"],"award-info":[{"award-number":["2023QNA050"]}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2023QH1160"],"award-info":[{"award-number":["2023QH1160"]}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2021QH1148"],"award-info":[{"award-number":["2021QH1148"]}]},{"name":"the Scientific and Technological Innovation Joint Capital Projects of Fujian Province","award":["2023Y9424"],"award-info":[{"award-number":["2023Y9424"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04503-5","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:54:40Z","timestamp":1769514880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of neoadjuvant therapy in elderly patients with T1b-T2N\u2009+\u2009esophageal cancer: a population-based cohort study"],"prefix":"10.1007","volume":"17","author":[{"given":"Jun-Peng","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Huang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Nian","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"4503_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"3","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin. 2024;3:229\u201363.","journal-title":"Ca-Cancer J Clin"},{"key":"4503_CR2","first-page":"582","volume":"6","author":"The Global","year":"2020","unstructured":"The Global. Regional, and National burden of oesophageal cancer and its attributable risk factors in 195 countries and Territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol. 2020;6:582\u201397.","journal-title":"Lancet Gastroenterol"},{"key":"4503_CR3","first-page":"275","volume":"4","author":"D Swaminathan","year":"2015","unstructured":"Swaminathan D, Swaminathan V. Geriatric oncology: problems with under-treatment within this population. Cancer Biol Med. 2015;4:275\u201383.","journal-title":"Cancer Biol Med"},{"key":"4503_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"4","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction Cancers, version 2.2023, Nccn clinical practice guidelines in oncology. J Natl Compr Canc Ne. 2023;4:393\u2013422.","journal-title":"J Natl Compr Canc Ne"},{"key":"4503_CR5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"9","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot J, Hulshof M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (Cross): Long-Term results of a randomised controlled trial. Lancet Oncol. 2015;9:1090\u20138.","journal-title":"Lancet Oncol"},{"key":"4503_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"8","author":"H Yang","year":"2021","unstructured":"Yang H, Liu H, Chen Y, et al. Long-Term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the Neocrtec5010 randomized clinical trial. Jama Surg. 2021;8:721\u20139.","journal-title":"Jama Surg"},{"key":"4503_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ijrobp.2017.02.021","volume":"4","author":"SC Lester","year":"2017","unstructured":"Lester SC, Lin SH, Chuong M, et al. A Multi-Institutional analysis of trimodality therapy for esophageal cancer in elderly patients. Int J Radiat Oncol. 2017;4:820\u20138.","journal-title":"Int J Radiat Oncol"},{"key":"4503_CR8","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL. AJCC cancer staging manual. Springer; 2017."},{"key":"4503_CR9","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","volume":"17","author":"BD Smith","year":"2009","unstructured":"Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;17:2758\u201365.","journal-title":"J Clin Oncol"},{"key":"4503_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-024-02013-y","volume":"1","author":"D Wen","year":"2024","unstructured":"Wen D, Xiao H, Gao Y, Zeng H, Deng J. N6-methyladenosine-modified Senp1, identified by Igf2Bp3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating Akt signal via de-sumoylating Hdac2. Mol Cancer. 2024;1:116.","journal-title":"Mol Cancer"},{"key":"4503_CR11","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jamaoncol.2019.2055","volume":"12","author":"EB Ludmir","year":"2019","unstructured":"Ludmir EB, Mainwaring W, Lin TA, et al. Factors associated with age disparities among cancer clinical trial participants. Jama Oncol. 2019;12:1769\u201373.","journal-title":"Jama Oncol"},{"key":"4503_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/jso.24789","volume":"8","author":"AC Hollis","year":"2017","unstructured":"Hollis AC, Quinn LM, Hodson J, et al. Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer. J Surg Oncol. 2017;8:1114\u201322.","journal-title":"J Surg Oncol"},{"key":"4503_CR13","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1245\/s10434-023-14692-w","volume":"4","author":"Y Koterazawa","year":"2024","unstructured":"Koterazawa Y, Oshikiri T, Goto H, et al. Impact of tumor size on survival outcome in esophageal squamous cell carcinoma after esophagectomy following neoadjuvant chemotherapy. Ann Surg Oncol. 2024;4:2482\u20139.","journal-title":"Ann Surg Oncol"},{"key":"4503_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.athoracsur.2018.05.018","volume":"4","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang Y, Qu P, et al. Prognostic value of tumor length for cause-specific death in resectable esophageal cancer. Ann Thorac Surg. 2018;4:1038\u201346.","journal-title":"Ann Thorac Surg"},{"key":"4503_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SLA.0000000000004798","volume":"2","author":"X Guo","year":"2023","unstructured":"Guo X, Wang Z, Yang H, et al. Impact of lymph node dissection on survival after neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: from the results of Neocrtec5010, a randomized multicenter study. Ann Surg. 2023;2:259\u201366.","journal-title":"Ann Surg"},{"key":"4503_CR16","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/SLA.0000000000003598","volume":"4","author":"S Raja","year":"2021","unstructured":"Raja S, Rice TW, Murthy SC, et al. Value of lymphadenectomy in patients receiving neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg. 2021;4:e320\u20137.","journal-title":"Ann Surg"},{"key":"4503_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.athoracsur.2019.04.008","volume":"3","author":"B Kidane","year":"2019","unstructured":"Kidane B, Korst RJ, Weksler B, et al. Neoadjuvant therapy vs upfront surgery for clinical T2N0 esophageal cancer: a systematic review. Ann Thorac Surg. 2019;3:935\u201344.","journal-title":"Ann Thorac Surg"},{"key":"4503_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2023.10.006","author":"DR Mann","year":"2024","unstructured":"Mann DR, Engelhardt KE, Gibney BC, et al. Defining pathologic upstaging in Ct1B esophageal cancer: should we consider neoadjuvant therapy? J Surg Res. 2024. https:\/\/doi.org\/10.1016\/j.jss.2023.10.006.","journal-title":"J Surg Res"},{"key":"4503_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1245\/s10434-023-14441-z","volume":"1","author":"JH Rodriguez-Quintero","year":"2024","unstructured":"Rodriguez-Quintero JH, Kamel MK, Jindani R, et al. The effect of neoadjuvant therapy on esophagectomy for Ct2N0M0 esophageal adenocarcinoma. Ann Surg Oncol. 2024;1:228\u201338.","journal-title":"Ann Surg Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04503-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04503-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04503-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:56:02Z","timestamp":1771422962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04503-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4503"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04503-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was exempt from ethical clearance because of its public availability in the SEER database. We use SEER public research data, so written informed consent for participation was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We use SEER public research data, so written informed consent for publication was not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}